Hepatic insulin signalling is dispensable for suppression of glucose output by insulin in vivo

Titchenell, Paul M.; Chu, Qingwei; Monks, Bobby R.; Birnbaum, Morris J.

doi:10.1038/ncomms8078

Cited by 169Metabolism, Diabetes, and CancerFOXO transcription factor regulationPancreatic function and diabetes

Hepatic insulin signalling is dispensable for suppression of glucose output by insulin in vivo

Open access

Titchenell, Paul M., Chu, Qingwei, Monks, Bobby R., Birnbaum, Morris J.·2015·Nature Communications

DOI 10.1038/ncomms8078PMC PMC4429930

Open this paper in CoChat — free account Open PDF

Abstract

Insulin signalling and nutrient levels coordinate the metabolic response to feeding in the liver. Insulin signals in hepatocytes to activate Akt, which inhibits Foxo1 suppressing hepatic glucose production (HGP) and allowing the transition to the postprandial state. Here we provide genetic evidence that insulin regulates HGP by both direct and indirect hepatic mechanisms. Liver-specific ablation of the IR (L-Insulin Receptor KO) induces glucose intolerance, insulin resistance and prevents the appropriate transcriptional response to feeding. Liver-specific deletion of Foxo1 (L-IRFoxo1DKO) rescues glucose tolerance and allows for normal suppression of HGP and gluconeogenic gene expression in response to insulin, despite lack of autonomous liver insulin signalling. These data indicate that in the absence of Foxo1, insulin signals via an intermediary extrahepatic tissue to regulate liver glucose production. Importantly, a hepatic mechanism distinct from the IR–Akt–Foxo1 axis exists to regulate glucose production. Insulin and the transcription factor FoxO1 are key regulators of hepatic glucose metabolism. Here, Titchenell et al. provide evidence for the existence of an insulin-dependent extrahepatic pathway that is fully capable of regulating hepatic glucose production in the absence of hepatic FoxO1.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/ncomms8078

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Intact hepatic insulin signaling is dispensable for the postprandial repression of hepatic glucose production in the absence of hepatic FoxO1, highlighting the importance of hypothalamic insulin signaling in the control of liver glucose metabolism.
“Intact hepatic insulin signaling is, however, dispensable for the postprandial repression of hepatic glucose production in the absence of hepatic FoxO1 32, 33, highlighting the importance of hypothalamic insulin signaling in the control of liver glucose metabolism 34.”
From Inter‐organ communication: a gatekeeper for metabolic health (2019) · cites this paper as [33]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Insulin signalling and the regulation of glucose and lipid metabolism
Saltiel, A. R., & Kahn, C. R. (2001) · Nature · doi:10.1038/414799a · Cited by 5,326 · see citing works
Insulin-regulated hepatic gluconeogenesis through FOXO1–PGC-1α interaction
Puigserver, P., Rhee, J., Donovan, J., Walkey, C. J., Yoon, J. C., Oriente, F., Kitamura, Y., Altomonte, J., Dong, H., Accili, D., et al. (2003) · Nature · doi:10.1038/nature01667 · Cited by 1,487 · see citing works
Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction.
Michael, M. D., Kulkarni, R. N., Postic, C., Previs, S. F., Shulman, G. I., Magnuson, M. A., & Kahn, C. R. (2000) · Molecular Cell · doi:10.1016/s1097-2765(05)00015-8 · Cited by 1,296 · see citing works
A Muscle-Specific Insulin Receptor Knockout Exhibits Features of the Metabolic Syndrome of NIDDM without Altering Glucose Tolerance
Brüning, J. C., Michael, M. D., Winnay, J. N., Hayashi, T., Hörsch, D., Accili, D., Goodyear, L. J., & Kahn, C. R. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80155-0 · Cited by 1,183 · see citing works
The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism
Koo, S., Flechner, L., Qi, L., Zhang, X., Screaton, R. A., Jeffries, S., Hedrick, S. A., Xu, W., Boussouar, F., Brindle, P. K., et al. (2005) · Nature · doi:10.1038/nature03967 · Cited by 996 · see citing works
Spatial Control of the TSC Complex Integrates Insulin and Nutrient Regulation of mTORC1 at the Lysosome
Menon, S., Dibble, C. C., Talbott, G., Hoxhaj, G., Valvezan, A., Takahashi, H., Cantley, L., & Manning, B. (2014) · Cell · doi:10.1016/j.cell.2013.11.049 · Cited by 787 · see citing works
Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis
Li, S., Brown, M. S., & Goldstein, J. L. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914798107 · Cited by 733 · see citing works
Insulin Action in AgRP-Expressing Neurons Is Required for Suppression of Hepatic Glucose Production
Könner, A. C., Janoschek, R., Plum, L., Jordan, S. D., Rother, E., Ma, X., Xu, C., Enriori, P., Hampel, B., Barsh, G. S., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.004 · Cited by 695 · see citing works
Akt Stimulates Hepatic SREBP1c and Lipogenesis through Parallel mTORC1-Dependent and Independent Pathways
Yecies, J. L., Zhang, H., Menon, S., Liu, S., Yecies, D. W., Lipovsky, A. I., Görgün, C. Z., Kwiatkowski, D. J., Hotamışlıgil, G. S., Lee, C., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.06.002 · Cited by 662 · see citing works
Impaired Regulation of Hepatic Glucose Production in Mice Lacking the Forkhead Transcription Factor Foxo1 in Liver
Matsumoto, M., Pocai, A., Rossetti, L., DePinho, R. A., & Accili, D. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.08.006 · Cited by 616 · see citing works
Hepatocyte nuclear factor 4α controls the development of a hepatic epithelium and liver morphogenesis
Parviz, F., Matullo, C., Garrison, W. D., Savatski, L., Adamson, J. W., Ning, G., Kaestner, K. H., Rossi, J. M., Zaret, K. S., & Duncan, S. A. (2003) · Nature Genetics · doi:10.1038/ng1175 · Cited by 588 · see citing works
Insulin Stimulates Phosphorylation of the Forkhead Transcription Factor FKHR on Serine 253 through a Wortmannin-sensitive Pathway
Nakae, J., Park, B., & Accili, D. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.23.15982 · Cited by 474 · see citing works
Inactivation of Hepatic Foxo1 by Insulin Signaling Is Required for Adaptive Nutrient Homeostasis and Endocrine Growth Regulation
Dong, X. C., Copps, K. D., Guo, S., Li, Y., Kollipara, R., DePinho, R. A., & White, M. F. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.06.006 · Cited by 463 · see citing works
Hormonal regulation of hepatic glucose production in health and disease
Lin, H. V., & Accili, D. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.06.003 · Cited by 429 · see citing works
Insulin modulates gluconeogenesis by inhibition of the coactivator TORC2
Dentin, R., Liu, Y., Koo, S., Hedrick, S. A., Vargas, T., Heredia, J., Yates, J. R., & Montminy, M. (2007) · Nature · doi:10.1038/nature06128 · Cited by 400 · see citing works
Central nervous system control of metabolism
Myers, M. G., & Olson, D. P. (2012) · Nature · doi:10.1038/nature11705 · Cited by 399 · see citing works
Insulin regulates liver metabolism in vivo in the absence of hepatic Akt and Foxo1
Lu, M., Wan, M., Leavens, K. F., Chu, Q., Monks, B. R., Fernandez, S., Ahima, R. S., Ueki, K., Kahn, C. R., & Birnbaum, M. J. (2012) · Nature Medicine · doi:10.1038/nm.2686 · Cited by 396 · see citing works
Self-citation
A brain-liver circuit regulates glucose homeostasis
Pocai, A., Obici, S., Schwartz, G. J., & Rossetti, L. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2004.11.001 · Cited by 392 · see citing works
Pathogenesis of fasting and postprandial hyperglycemia in type 2 diabetes: implications for therapy.
Rizza, R. A. (2010) · Diabetes · doi:10.2337/db10-1032 · Cited by 367 · see citing works
Mechanisms of disease: metabolic effects of growth hormone and insulin-like growth factor 1
LeRoith, D., & Yakar, S. (2007) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0427 · Cited by 344 · see citing works
Insulin Signaling in α Cells Modulates Glucagon Secretion In Vivo
Kawamori, D., Kurpad, A. J., Hu, J., Liew, C. W., Shih, J. L., Ford, E. L., Herrera, P. L., Polonsky, K. S., McGuinness, O. P., & Kulkarni, R. N. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.02.007 · Cited by 316 · see citing works
Cooperation between brain and islet in glucose homeostasis and diabetes
Schwartz, M. W., Seeley, R. J., Tschöp, M. H., Woods, S. C., Morton, G. J., Myers, M. G., & D’Alessio, D. A. (2013) · Nature · doi:10.1038/nature12709 · Cited by 315 · see citing works
Regulation of glucose homeostasis through a XBP-1–FoxO1 interaction
Zhou, Y., Lee, J., Reno, C. M., Sun, C., Park, S. W., Chung, J., Lee, J., Fisher, S. J., White, M. F., Biddinger, S. B., et al. (2011) · Nature Medicine · doi:10.1038/nm.2293 · Cited by 295 · see citing works
Role of hepatic STAT3 in brain-insulin action on hepatic glucose production
Inoue, H., Ogawa, W., Asakawa, A., Okamoto, Y., Nishizawa, A., Matsumoto, M., Teshigawara, K., Matsuki, Y., Watanabe, E., Hiramatsu, R., et al. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.009 · Cited by 294 · see citing works
Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs.
Rebrin, K., Steil, G. M., Mittelman, S. D., & Bergman, R. N. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118846 · Cited by 288 · see citing works
Two novel phosphorylation sites on FKHR that are critical for its nuclear exclusion
Rena, G., Woods, Y. L., Prescott, A. R., Peggie, M., Unterman, T. G., Williams, M. R., & Cohen, P. (2002) · The EMBO Journal · doi:10.1093/emboj/21.9.2263 · Cited by 241 · see citing works
Insulin signaling is required for insulin’s direct and indirect action on hepatic glucose production
Fisher, S. J., & Kahn, C. R. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16426 · Cited by 211 · see citing works
Hepatic Insulin Signaling Is Required for Obesity-Dependent Expression of SREBP-1c mRNA but Not for Feeding-Dependent Expression
Haas, J. T., Miao, J., Chanda, D., Wang, Y., Zhao, E., Haas, M. E., Hirschey, M. D., Vaitheesvaran, B., Farese, R. V., Kurland, I. J., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.05.002 · Cited by 207 · see citing works
Adiponectin suppresses gluconeogenic gene expression in mouse hepatocytes independent of LKB1-AMPK signaling
Miller, R., Chu, Q., Lay, J. E. L., Scherer, P. E., Ahima, R. S., Kaestner, K. H., Foretz, M., Viollet, B., & Birnbaum, M. J. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45942 · Cited by 178 · see citing works
Self-citation
Targeting Foxo1 in Mice Using Antisense Oligonucleotide Improves Hepatic and Peripheral Insulin Action
Samuel, V. T., Choi, C. S., Phillips, T. G., Romanelli, A. J., Geisler, J. G., Bhanot, S., McKay, R. A., Monia, B. P., Shutter, J. R., Lindberg, R. A., et al. (2006) · Diabetes · doi:10.2337/db05-0705 · Cited by 177 · see citing works
Insulin action in the brain contributes to glucose lowering during insulin treatment of diabetes
Gelling, R. W., Morton, G. J., Morrison, C. D., Niswender, K. D., Myers, M. G., Rhodes, C. J., & Schwartz, M. W. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2005.11.013 · Cited by 169 · see citing works
Insulin signaling to hepatic lipid metabolism in health and disease
Leavens, K. F., & Birnbaum, M. J. (2011) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2011.562481 · Cited by 162 · see citing works
Self-citation
Postprandial Hepatic Lipid Metabolism Requires Signaling though Akt2 Independent of the Transcription Factors FoxA2, FoxO1 and SREBP1c
Wan, M., Leavens, K. F., Saleh, D., Easton, R., Guertin, D., Peterson, T. R., Kaestner, K., Sabatini, D., & Birnbaum, M. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.09.001 · Cited by 138 · see citing works
Self-citation
Fatty Acids Mediate the Acute Extrahepatic Effects of Insulin on Hepatic Glucose Production in Humans
Lewis, G., Vranic, M., Harley, P. H., & Giacca, A. (1997) · Diabetes · doi:10.2337/diab.46.7.1111 · Cited by 134 · see citing works
Restoration of liver insulin signaling in Insr knockout mice fails to normalize hepatic insulin action
Okamoto, H., Obici, S., Accili, D., & Rossetti, L. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23096 · Cited by 121 · see citing works
Brain insulin action augments hepatic glycogen synthesis without suppressing glucose production or gluconeogenesis in dogs
Ramnanan, C. J., Saraswathi, V., Smith, M. S., Donahue, E. P., Farmer, B., Farmer, T. D., Neal, D. W., Williams, P. E., Lautz, M., Mari, A., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45472 · Cited by 94 · see citing works
Inhibition of lipolysis causes suppression of endogenous glucose production independent of changes in insulin
Mittelman, S. D., & Bergman, R. N. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.279.3.e630 · Cited by 85 · see citing works
A Noncanonical, GSK3-Independent Pathway Controls Postprandial Hepatic Glycogen Deposition
Wan, M., Leavens, K. F., Hunter, R. W., Koren, S., von Wilamowitz-Moellendorff, A., Lu, M., Satapati, S., Chu, Q., Sakamoto, K., Burgess, S. C., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.06.001 · Cited by 79 · see citing works
Self-citation
The Relation of Insulin to Liver Metabolism
Levine, R., & Fritz, I. B. (1956) · Diabetes · doi:10.2337/diab.5.3.209 · Cited by 70 · see citing works
Evidence against a Physiologic Role for Acute Changes in CNS Insulin Action in the Rapid Regulation of Hepatic Glucose Production
Ramnanan, C. J., Edgerton, D. S., & Cherrington, A. D. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.03.006 · Cited by 56 · see citing works
Interaction Between the Central and Peripheral Effects of Insulin in Controlling Hepatic Glucose Metabolism in the Conscious Dog
Ramnanan, C. J., Kraft, G., Smith, M. S., Farmer, B., Neal, D. W., Williams, P. E., Lautz, M., Farmer, T. E., Donahue, E. P., Cherrington, A. D., et al. (2012) · Diabetes · doi:10.2337/db12-0148 · Cited by 48 · see citing works
Effects of small changes in glucagon on glucose production during a euglycemic, hyperinsulinemic clamp
Myers, S. R., Diamond, M. P., Adkins-Marshall, B. A., Williams, P. E., Stinsen, R., & Cherrington, A. D. (1991) · Metabolism · doi:10.1016/0026-0495(91)90194-2 · Cited by 47 · see citing works
The AKTion in non-canonical insulin signaling
Cheng, Z., & White, M. F. (2012) · Nature Medicine · doi:10.1038/nm.2694 · Cited by 38 · see citing works

Flagged first, then by citations

Sorted by citations

Mechanisms of Insulin Action and Insulin Resistance
Petersen, M. C., & Shulman, G. I. (2018) · Physiological Reviews · doi:10.1152/physrev.00063.2017 · Cited by 3,028 · see citing works
The PI3K/AKT Pathway in Obesity and Type 2 Diabetes
Huang, X., Liu, G., Guo, J., & Su, Z. (2018) · International Journal of Biological Sciences · doi:10.7150/ijbs.27173 · Cited by 1,673 · see citing works
“Additionally, those mice still maintained the normal postprandial state, even in the absence of canonical liver insulin signalling [85, 87].”
BackgroundResult
The integrative biology of type 2 diabetes
Roden, M., & Shulman, G. I. (2019) · Nature · doi:10.1038/s41586-019-1797-8 · Cited by 1,167 · see citing works
Regulation of hepatic glucose metabolism in health and disease
Petersen, M. C., Vatner, D. F., & Shulman, G. I. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.80 · Cited by 1,131 · see citing works
NAFLD and diabetes mellitus
Tilg, H., Moschen, A. R., & Roden, M. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.147 · Cited by 1,002 · see citing works
A branched-chain amino acid metabolite drives vascular fatty acid transport and causes insulin resistance
Jang, C., Oh, S. F., Wada, S., Rowe, G. C., Liu, L., Chan, M. C., Rhee, J., Hoshino, A., Kim, B., Ibrahim, A., et al. (2016) · Nature Medicine · doi:10.1038/nm.4057 · Cited by 589 · see citing works
Self-citation
Insulin regulation of gluconeogenesis
Hatting, M., Tavares, C. D. J., Sharabi, K., Rines, A. K., & Puigserver, P. (2017) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13435 · Cited by 589 · see citing works
Dietary fructose feeds hepatic lipogenesis via microbiota-derived acetate
Zhao, S., Jang, C., Liu, J., Uehara, K., Gilbert, M., Izzo, L., Zeng, X., Trefely, S., Fernandez, S., Carrer, A., et al. (2020) · Nature · doi:10.1038/s41586-020-2101-7 · Cited by 553 · see citing works
Self-citation
Role of Insulin Resistance in MAFLD
Sakurai, Y., Kubota, N., Yamauchi, T., & Kadowaki, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084156 · Cited by 448 · see citing works
Unraveling the Regulation of Hepatic Metabolism by Insulin
Titchenell, P. M., Lazar, M. A., & Birnbaum, M. J. (2017) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2017.03.003 · Cited by 434 · see citing works
Self-citation
Fox transcription factors: from development to disease
Golson, M. L., & Kaestner, K. H. (2016) · Development · doi:10.1242/dev.112672 · Cited by 406 · see citing works
Insulin Receptor Isoforms in Physiology and Disease: An Updated View
Belfiore, A., Malaguarnera, R., Vella, V., Lawrence, M. C., Sciacca, L., Frasca, F., Morrione, A., & Vigneri, R. (2017) · Endocrine Reviews · doi:10.1210/er.2017-00073 · Cited by 376 · see citing works
FoxO integration of insulin signaling with glucose and lipid metabolism
Lee, S., & Dong, H. H. (2017) · Journal of Endocrinology · doi:10.1530/joe-17-0002 · Cited by 361 · see citing works
Resolving the paradox of hepatic insulin resistance
Santoleri, D., & Titchenell, P. M. (2019) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2018.10.016 · Cited by 336 · see citing works
Self-citation
Hepatic Selective Insulin Resistance at the Intersection of Insulin Signaling and Metabolic Dysfunction-Associated Steatotic Liver Disease
Bo, T., Gao, L., Yao, Z., Shao, S., Wang, X., Proud, C. G., & Zhao, J. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.04.006 · Cited by 293 · see citing works
Direct Hepatocyte Insulin Signaling Is Required for Lipogenesis but Is Dispensable for the Suppression of Glucose Production
Titchenell, P. M., Quinn, W. J., Lu, M., Chu, Q., Lu, W., Li, C., Chen, H., Monks, B. R., Chen, J., Rabinowitz, J. D., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.04.022 · Cited by 281 · see citing works
Self-citation
FoxO1 integrates direct and indirect effects of insulin on hepatic glucose production and glucose utilization
O-Sullivan, I., Zhang, W., Wasserman, D. H., Liew, C. W., Liu, J., Paik, J., DePinho, R. A., Stolz, D. B., Kahn, C. R., Schwartz, M. W., et al. (2015) · Nature Communications · doi:10.1038/ncomms8079 · Cited by 228 · see citing works
Metabolic drivers of non-alcoholic fatty liver disease
Bence, K. K., & Birnbaum, M. J. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101143 · Cited by 223 · see citing works
Self-citation
Hepatic NADH reductive stress underlies common variation in metabolic traits
Goodman, R. P., Markhard, A. L., Shah, H., Sharma, R., Skinner, O. S., Clish, C. B., Deik, A., Patgiri, A., Hsu, Y.-H. H., Masia, R., et al. (2020) · Nature · doi:10.1038/s41586-020-2337-2 · Cited by 207 · see citing works
Brain insulin signalling in metabolic homeostasis and disease
Scherer, T., Sakamoto, K., & Buettner, C. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00498-x · Cited by 205 · see citing works
New targets for NAFLD
Parlati, L., Régnier, M., Guillou, H., & Postic, C. (2021) · JHEP Reports · doi:10.1016/j.jhepr.2021.100346 · Cited by 190 · see citing works
Ins and outs of the TCA cycle: the central role of anaplerosis
Inigo, M., Deja, S., & Burgess, S. C. (2021) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-120420-025558 · Cited by 189 · see citing works
Inter‐organ communication: a gatekeeper for metabolic health
Castillo‐Armengol, J., Fajas, L., & Lopez‐Mejia, I. C. (2019) · The EMBO Reports · doi:10.15252/embr.201947903 · Cited by 178 · see citing works
Adipose tissue mTORC2 regulates ChREBP-driven de novo lipogenesis and hepatic glucose metabolism
Tang, Y., Wallace, M., Sánchez-Gurmaches, J., Hsiao, W., Li, H., Lee, P. L., Vernia, S., Metallo, C. M., & Guertin, D. A. (2016) · Nature Communications · doi:10.1038/ncomms11365 · Cited by 172 · see citing works
Imbalanced Insulin Actions in Obesity and Type 2 Diabetes: Key Mouse Models of Insulin Signaling Pathway
Kubota, T., Kubota, N., & Kadowaki, T. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.03.004 · Cited by 169 · see citing works
Ginsenoside Rg1 Inhibits Glucagon-Induced Hepatic Gluconeogenesis through Akt-FoxO1 Interaction
Liu, Q., Zhang, F.-G., Zhang, W., Pan, A., Yang, Y., Liu, J., Li, P., Liu, B., & Qi, L. (2017) · Theranostics · doi:10.7150/thno.18788 · Cited by 156 · see citing works
Central injection of fibroblast growth factor 1 induces sustained remission of diabetic hyperglycemia in rodents
Scarlett, J. M., Rojas, J. M., Matsen, M. E., Kaiyala, K. J., Stefanovski, D., Bergman, R. N., Hồng, N. T., Dorfman, M. D., Lantier, L., Wasserman, D. H., et al. (2016) · Nature Medicine · doi:10.1038/nm.4101 · Cited by 151 · see citing works
Obesity: Pathophysiology, monosodium glutamate-induced model and anti-obesity medicinal plants
Hernández-Bautista, R., Mahmoud, A. M., Königsberg, M., & López‐Díazguerrero, N. E. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.12.108 · Cited by 145 · see citing works
Long Noncoding RNA lncSHGL Recruits hnRNPA1 to Suppress Hepatic Gluconeogenesis and Lipogenesis
Wang, J., Yang, W., Chen, Z., Chen, J., Meng, Y., Feng, B., Sun, L., Dou, L., Li, J., Cui, Q., et al. (2018) · Diabetes · doi:10.2337/db17-0799 · Cited by 137 · see citing works
Potential Nexus of Non-alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: Insulin Resistance Between Hepatic and Peripheral Tissues
Mu, W., Cheng, X., Liu, Y., Lv, Q., Gao-lin, L., Zhang, J.-G., & Li, X. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01566 · Cited by 125 · see citing works
The PI3K/Akt signaling axis and type 2 diabetes mellitus (T2DM): From mechanistic insights into possible therapeutic targets
Taheri, R., Mokhtari, Y., Yousefi, A., & Bashash, D. (2024) · Cell Biology International · doi:10.1002/cbin.12189 · Cited by 109 · see citing works
Inactivating hepatic follistatin alleviates hyperglycemia
Tao, R., Wang, C., Stöhr, O., Qiu, W., Hu, Y., Miao, J., Dong, X. C., Leng, S., Stefater, M., Stylopoulos, N., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0048-0 · Cited by 104 · see citing works
Intercellular Transmission of Hepatic ER Stress in Obesity Disrupts Systemic Metabolism
Tirosh, A., Tuncman, G., Calay, E. S., RATHAUS, M., Ron, I., Tirosh, A., Yalçın, A., Lee, Y. G., Livne, R., Ron, S., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.11.009 · Cited by 104 · see citing works
Muscle Directs Diurnal Energy Homeostasis through a Myokine-Dependent Hormone Module in Drosophila
Zhao, X. L., & Karpac, J. (2017) · Current Biology · doi:10.1016/j.cub.2017.06.004 · Cited by 98 · see citing works
Hypothalamic Control of Systemic Glucose Homeostasis: The Pancreas Connection
Pozo, M., & Claret, M. (2018) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2018.05.001 · Cited by 97 · see citing works
Hypothalamic Insulin Resistance in Obesity: Effects on Glucose Homeostasis
Chen, W., Balland, É., & Cowley, M. A. (2017) · Neuroendocrinology · doi:10.1159/000455865 · Cited by 99 · see citing works
mTORC1 stimulates phosphatidylcholine synthesis to promote triglyceride secretion
Quinn, W. J., Wan, M., Shewale, S. V., Gelfer, R., Rader, D. J., Birnbaum, M. J., & Titchenell, P. M. (2017) · Journal of Clinical Investigation · doi:10.1172/jci96036 · Cited by 97 · see citing works
Self-citation
Hepatic Dysfunction Caused by Consumption of a High-Fat Diet
Soltis, A. R., Kennedy, N. J., Xin, X., Zhou, F., Ficarro, S. B., Yap, Y. S., Matthews, B. J., Lauffenburger, D. A., White, F. M., Marto, J. A., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.11.059 · Cited by 96 · see citing works
Sphingolipid metabolism in non-alcoholic fatty liver diseases
Régnier, M., Polizzi, A., Guillou, H., & Loiseau, N. (2018) · Biochimie · doi:10.1016/j.biochi.2018.07.021 · Cited by 85 · see citing works
Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications
Truong, X. T., & Lee, D. H. (2025) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2025.0644 · Cited by 84 · see citing works
“In mice, concomitant deletion of FoxO1 in an AKT-deficient liver is not sufficient to drive DNL but restores insulin sensitivity and glucose tolerance, suggesting there are other pathways downstream of AKT that contribute to DNL [12,32].”
Integrated Regulation of Hepatic Lipid and Glucose Metabolism by Adipose Triacylglycerol Lipase and FoxO Proteins
Zhang, W., Bu, S. Y., Mashek, M. T., O‐Sullivan, I., Sibai, Z., Khan, S. A., Ilkayeva, O., Newgard, C. B., Mashek, D. G., & Unterman, T. G. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.03.021 · Cited by 80 · see citing works
Physiological Suppression of Lipotoxic Liver Damage by Complementary Actions of HDAC3 and SCAP/SREBP
Papazyan, R., Sun, Z., Kim, Y. H., Titchenell, P. M., Hill, D. A., Lu, W., Damle, M., Wan, M., Zhang, Y., Briggs, E. R., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.10.012 · Cited by 77 · see citing works
Self-citation
Fu Brick Tea Manages HFD/STZ-Induced Type 2 Diabetes by Regulating the Gut Microbiota and Activating the IRS1/PI3K/Akt Signaling Pathway
Qi, B., Ren, D., Li, T., Niu, P., Zhang, X., Yang, X., & Xiao, J. (2022) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c02400 · Cited by 76 · see citing works
Nonalcoholic fatty liver disease and type 2 diabetes: pathophysiological mechanisms shared between the two faces of the same coin
Acierno, C., Caturano, A., Pafundi, P. C., Nevola, R., Adinolfi, L. E., & Sasso, F. C. (2020) · Exploration of Medicine · doi:10.37349/emed.2020.00019 · Cited by 76 · see citing works
Metabolic Role of PTEN in Insulin Signaling and ResistancePreprint
Li, Y. Z., Cristofano, A. D., & Woo, M. (2020) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a036137 · Cited by 70 · see citing works
Hepatic Glucagon Receptor Signaling Enhances Insulin-Stimulated Glucose Disposal in Rodents
Kim, T., Holleman, C. L., Nason, S. R., Arble, D. M., Ottaway, N., Chabenne, J. R., Loyd, C., Kim, J., Sandoval, D. A., Drucker, D. J., et al. (2018) · Diabetes · doi:10.2337/db18-0068 · Cited by 69 · see citing works
LRG1 is an adipokine that mediates obesity-induced hepatosteatosis and insulin resistance
He, S., Ryu, J., Liu, J., Luo, H., Lv, Y., Langlais, P. R., Wen, J., Dong, F., Sun, Z., Xia, W., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci148545 · Cited by 69 · see citing works
Triglycerides in Nonalcoholic Fatty Liver Disease: Guilty Until Proven Innocent
Semova, I., & Biddinger, S. B. (2021) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.12.001 · Cited by 67 · see citing works
Insulin signaling and reduced glucocorticoid receptor activity attenuate postprandial gene expression in liver
Kalviša, A., Siersbæk, M. S., Præstholm, S. M., Christensen, L. J. L., Nielsen, R., Stöhr, O., Vettorazzi, S., Tuckermann, J. P., White, M. F., Mandrup, S., et al. (2018) · PLoS Biology · doi:10.1371/journal.pbio.2006249 · Cited by 64 · see citing works
The role of adipose tissue dysfunction in hepatic insulin resistance and T2D
Sancar, G., & Birkenfeld, A. L. (2024) · Journal of Endocrinology · doi:10.1530/joe-24-0115 · Cited by 64 · see citing works
FoxO1 antagonist suppresses autophagy and lipid droplet growth in adipocytes
Liu, L., Zheng, L., Zou, P., Brooke, J., Smith, C., Long, Y. C., Almeida, F. A., Liu, D., & Cheng, Z. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1192732 · Cited by 60 · see citing works
The adipocyte supersystem of insulin and cAMP signaling
Guilherme, A., Rowland, L. A., Wang, H., & Czech, M. (2022) · Trends in Cell Biology · doi:10.1016/j.tcb.2022.07.009 · Cited by 59 · see citing works
Targeting insulin to the liver corrects defects in glucose metabolism caused by peripheral insulin delivery
Edgerton, D. S., Scott, M. F., Farmer, B., Williams, P. E., Madsen, P., Kjeldsen, T., Brand, C. L., Fledelius, C., Nishimura, E., & Cherrington, A. D. (2019) · JCI Insight · doi:10.1172/jci.insight.126974 · Cited by 59 · see citing works
Glucoregulatory Relevance of Small Intestinal Nutrient Sensing in Physiology, Bariatric Surgery, and Pharmacology
Duca, F. A., Bauer, P. V., Hamr, S. C., & Lam, T. K. T. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.07.003 · Cited by 56 · see citing works
A bioinformatics and transcriptomics based investigation reveals an inhibitory role of Huanglian-Renshen-Decoction on hepatic glucose production of T2DM mice via PI3K/Akt/FoxO1 signaling pathway
Wu, F., Shao, Q., Xia, Q., Hu, M., Zhao, Y. Q., Wang, D., Fang, K., Xu, L., Zou, X., Chen, Z., et al. (2021) · Phytomedicine · doi:10.1016/j.phymed.2021.153487 · Cited by 55 · see citing works
Hypothalamic growth hormone receptor (GHR) controls hepatic glucose production in nutrient-sensing leptin receptor (LepRb) expressing neurons
Cady, G., Landeryou, T., Garratt, M., Kopchick, J. J., Qi, N., García-Galiano, D., Elias, C. F., Myers, M. G., Miller, R. A., Sandoval, D. A., et al. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.03.001 · Cited by 52 · see citing works
Liver and insulin resistance: New wine in old bottle!!!
Patel, B. M., & Goyal, R. K. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172657 · Cited by 50 · see citing works
Insulin Regulation of Hepatic Lipid Homeostasis
Uehara, K., Santoleri, D., Whitlock, A. E. G., & Titchenell, P. M. (2023) · Comprehensive Physiology · doi:10.1002/cphy.c220015 · Cited by 49 · see citing works
Self-citation
Pathophysiological Relationship between Type 2 Diabetes Mellitus and Metabolic Dysfunction-Associated Steatotic Liver Disease: Novel Therapeutic Approaches
Ferdous, S.-E., & Ferrell, J. M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168731 · Cited by 49 · see citing works
The adipokine sFRP4 induces insulin resistance and lipogenesis in the liver
Hörbelt, T., Knebel, B., Fahlbusch, P., Barbosa, D., de Wiza, D. H., de Velde, F. V., Nieuwenhove, Y. V., Lapauw, B., Thoresen, G. H., Al‐Hasani, H., et al. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.07.008 · Cited by 46 · see citing works
Modeling and therapeutic targeting of inflammation-induced hepatic insulin resistance using human iPSC-derived hepatocytes and macrophages
Gröger, M., Matsuo, K., Arash, E. H., Pereira, A., Guillou, D. L., Pino, C., Telles-Silva, K. A., Maher, J. J., Hsiao, E. C., & Willenbring, H. (2023) · Nature Communications · doi:10.1038/s41467-023-39311-w · Cited by 44 · see citing works
MicroRNA-21 regulates hepatic glucose metabolism by targeting FOXO1
Luo, A., Yan, H., Liang, J., Du, C., Zhao, X., Sun, L., & Chen, Y. (2017) · Gene · doi:10.1016/j.gene.2017.06.024 · Cited by 44 · see citing works
Astragaloside IV Inhibits Adipose Lipolysis and Reduces Hepatic Glucose Production via Akt Dependent PDE3B Expression in HFD-Fed Mice
Du, Q., Zhang, S., Li, A., Mohammad, I. S., Liu, B., & Li, Y. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00015 · Cited by 44 · see citing works
Regulation of Glucose Production in the Pathogenesis of Type 2 Diabetes
Sargsyan, A., & Herman, M. A. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1195-5 · Cited by 41 · see citing works
Niacin fine‐tunes energy homeostasis through canonical GPR109A signaling
Ye, L., Cao, Z., Lai, X., Wang, W., Guo, Z., Yan, L., Wang, Y., Shi, Y., & Zhou, N. (2018) · The FASEB Journal · doi:10.1096/fj.201801951r · Cited by 39 · see citing works
Hypoinsulinaemic, hypoketotic hypoglycaemia due to mosaic genetic activation of PI3-kinase
Leiter, S. M., Parker, V., Welters, A., Knox, R. G., Rocha, N., Clark, G. R., Payne, F., Lotta, L. A., Harris, J. R., Guerrero-Fernández, J., et al. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0132 · Cited by 38 · see citing works
Hepatocyte ABCA1 Deletion Impairs Liver Insulin Signaling and Lipogenesis
Key, C.-C. C., Liu, M., Kurtz, C. L., Chung, S., Boudyguina, E. Y., Dinh, T. A., Bashore, A. C., Phelan, P. E., Freedman, B. I., Osborne, T. F., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.05.032 · Cited by 38 · see citing works
High‐fat diet in a mouse insulin‐resistant model induces widespread rewiring of the phosphotyrosine signaling network
Dittmann, A., Kennedy, N. J., Soltero, N. L., Morshed, N., Mana, M., Yilmaz, Ö. H., Davis, R. J., & White, F. M. (2019) · Molecular Systems Biology · doi:10.15252/msb.20198849 · Cited by 34 · see citing works
Haploinsufficiency of the Insulin Receptor in the Presence of a Splice-Site Mutation in<i>Ppp2r2a</i>Results in a Novel Digenic Mouse Model of Type 2 Diabetes
Goldsworthy, M., Bai, Y., Li, C.-M., Ge, H., Lamas, E., Hilton, H., Esapa, C. T., Baker, D., Baron, W., Juan, T., et al. (2016) · Diabetes · doi:10.2337/db15-1276 · Cited by 35 · see citing works
l -Cysteine supplementation increases insulin sensitivity mediated by upregulation of GSH and adiponectin in high glucose treated 3T3-L1 adipocytes
Elumalai, A., & Jain, S. K. (2017) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2017.07.016 · Cited by 31 · see citing works
Sirtuin function and metabolism: Role in pancreas, liver, and adipose tissue and their crosstalk impacting bone homeostasis
Avilkina, V., Chauveau, C., & Mhenni, O. G. (2021) · Bone · doi:10.1016/j.bone.2021.116232 · Cited by 32 · see citing works
Insulin Regulation of Hepatic Lipid Homeostasis
Uehara, K., Santoleri, D., Whitlock, A. E. G., & Titchenell, P. M. (2023) · Comprehensive physiology · doi:10.1002/j.2040-4603.2023.tb00269.x · Cited by 31 · see citing works
Self-citation
Deconstructing the Role of PKC Epsilon in Glucose Homeostasis
Schmitz‐Peiffer, C. (2020) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2020.01.016 · Cited by 30 · see citing works
Dietary inositol improved glucose and lipid metabolism mediated by the Insulin-PI3K-Akt signaling pathway in Pacific white shrimp (Litopenaeus vannamei)
Lu, J., Tao, X., Li, M., Zhang, X., Zhou, Q., Luo, J., Zhu, T., Jiao, L., & Jin, M. (2023) · Aquaculture · doi:10.1016/j.aquaculture.2023.739910 · Cited by 29 · see citing works
FoxO1 Is Required for Most of the Metabolic and Hormonal Perturbations Produced by Hepatic Insulin Receptor Deletion in Male Mice
Ling, A. V., Gearing, M. E., Semova, I., Shin, D., Clements, R. L., Lai, Z. W., & Biddinger, S. B. (2017) · Endocrinology · doi:10.1210/en.2017-00870 · Cited by 29 · see citing works
TOX4, an insulin receptor-independent regulator of hepatic glucose production, is activated in diabetic liver
Wang, L., Yu, J., Zhou, Q., Wang, X., Mukhanova, M., Du, W. J., Sun, L., Pajvani, U. B., & Accili, D. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.11.013 · Cited by 28 · see citing works
Regulation of Hepatic Glucose Metabolism by FoxO Proteins, an Integrated Approach
Unterman, T. G. (2017) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2017.10.005 · Cited by 28 · see citing works
Loss of FOXO transcription factors in the liver mitigates stress-induced hyperglycemia
Whitlock, A. E. G., Sostre‐Colón, J., Gavin, M. J., Martin, N. D., Baur, J. A., Sims, C. A., & Titchenell, P. M. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101246 · Cited by 27 · see citing works
Self-citation
Hepatic AKT orchestrates adipose tissue thermogenesis via FGF21-dependent and -independent mechanisms
Sostre‐Colón, J., Uehara, K., Whitlock, A. E. G., Gavin, M. J., Ishibashi, J., Potthoff, M. J., Seale, P., & Titchenell, P. M. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109128 · Cited by 27 · see citing works
Self-citation
Insulin–Dendrimer Nanocomplex for Multi‐Day Glucose‐Responsive Therapy in Mice and Swine
Xian, S., Xiang, Y., Liu, D., Fan, B., Mitrová, K., Ollier, R. C., Su, B., Alloosh, M. A., Jiráček, J., Sturek, M. S., et al. (2023) · Advanced Materials · doi:10.1002/adma.202308965 · Cited by 26 · see citing works
Increased intracellular iron in mouse primary hepatocytes in vitro causes activation of the Akt pathway but decreases its response to insulin
Varghese, J., James, J., Vaulont, S., McKie, A. T., & Jacob, M. (2018) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2018.05.022 · Cited by 27 · see citing works
Enhancement of Adiponectin Ameliorates Nonalcoholic Fatty Liver Disease via Inhibition of FoxO1 in Type I Diabetic Rats
Xie, X., Yan, D., Li, H., Zhu, Q., Li, J., Fang, Y., Cheung, C. W., Irwin, M. G., Xia, Z., & Lian, Q. (2018) · Journal of Diabetes Research · doi:10.1155/2018/6254340 · Cited by 24 · see citing works
Crosstalk between bone and other organs
Yuan, W., & Song, C. (2022) · Medical Review · doi:10.1515/mr-2022-0018 · Cited by 25 · see citing works
Adipocyte JAK2 Regulates Hepatic Insulin Sensitivity Independently of Body Composition, Liver Lipid Content, and Hepatic Insulin Signaling
Corbit, K. C., Camporez, J. P., Edmunds, L. R., Tran, J. L., Vera, N. B., Erion, D. M., Deo, R. C., Perry, R. J., Shulman, G. I., Jurczak, M. J., et al. (2017) · Diabetes · doi:10.2337/db17-0524 · Cited by 22 · see citing works
Myeloid-specific deletion of Zfp36 protects against insulin resistance and fatty liver in diet-induced obese mice
Caracciolo, V., Young, J., Gonzales, D. M., Ni, Y., Flowers, S. J., Summer, R. S., Waldman, S. A., Kim, J. K., Jung, D. Y., Noh, H. L., et al. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00224.2017 · Cited by 20 · see citing works
Partial impairment of insulin receptor expression mimics fasting to prevent diet-induced fatty liver disease
Merry, T. L., Hedges, C. P., Masson, S. W. C., Laube, B., Pöhlmann, D., Wueest, S., Walsh, M. E., Arnold, M., Langhans, W., Konrad, D., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15623-z · Cited by 21 · see citing works
Hepatic IGF2/H19 Epigenetic Alteration Induced Glucose Intolerance in Gestational Diabetes Mellitus Offspring via FoxO1 Mediation
Jiang, Y., Zhu, H., Chen, Z., Yu, Y., Guo, X., Chen, Y., Yang, M., Chen, B.-W., Sagnelli, M., Xu, D. Q., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.844707 · Cited by 21 · see citing works
An integrative transcriptional logic model of hepatic insulin resistance
Kitamoto, T., Kuo, T., Okabe, A., Kaneda, A., & Accili, D. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2102222118 · Cited by 21 · see citing works
Insulin Resistance in Type 2 Diabetes
Roden, M., Petersen, K. F., & Shulman, G. I. (2016) · Wiley eBooks · doi:10.1002/9781118924853.ch13 · Cited by 20 · see citing works
Modulation of Glucose Production by Central Insulin Requires IGF-1 Receptors in AgRP Neurons
Quipildor, G. F., Mao, K., Beltran, P. J., Barzilai, N., & Huffman, D. M. (2021) · Diabetes · doi:10.2337/db21-0028 · Cited by 19 · see citing works
IPMK modulates hepatic glucose production and insulin signaling
Jung, I., Anokye‐Danso, F., Jin, S., Ahima, R. S., & Kim, S. F. (2022) · Journal of Cellular Physiology · doi:10.1002/jcp.30827 · Cited by 19 · see citing works
FoxO1: mute for a tuned metabolism?
Cheng, Z. (2015) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2015.06.006 · Cited by 19 · see citing works
Exploring histone deacetylases in type 2 diabetes mellitus: pathophysiological insights and therapeutic avenues
Kumar, K. K., Aburawi, E. H., Ljubisavljević, M., Leow, M. K., Xu, F., Ansari, S. A., & Emerald, B. S. (2024) · Clinical Epigenetics · doi:10.1186/s13148-024-01692-0 · Cited by 18 · see citing works
Regulation of Hepatic Metabolism, Recent Advances, and Future Perspectives
Sharabi, K., Tavares, C. D. J., & Puigserver, P. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1224-4 · Cited by 18 · see citing works
Whole grains-derived functional ingredients against hyperglycemia: targeting hepatic glucose metabolism
Wang, Y., Fan, M., Qian, H., Ying, H., Li, Y., & Wang, L. (2023) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2023.2183382 · Cited by 18 · see citing works
Role of AMPD2 in impaired glucose tolerance induced by high fructose diet
Hudoyo, A. W., Hirase, T., Tandelilin, A., Honda, M., Shirai, M., Cheng, J., Morisaki, H., & Morisaki, T. (2017) · Molecular Genetics and Metabolism Reports · doi:10.1016/j.ymgmr.2017.07.006 · Cited by 18 · see citing works
MicroRNA-185 modulates CYP7A1 mediated cholesterol-bile acid metabolism through post-transcriptional and post-translational regulation of FoxO1
Zhang, J., Wang, X., Huajun, J., Yang, F., Du, Y., Wang, L., & Hong, B. (2022) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2022.03.007 · Cited by 18 · see citing works
Estradiol (E2) Improves Glucose-Stimulated Insulin Secretion and Stabilizes GDM Progression in a Prediabetic Mouse Model
Liebmann, M., Pfeifer, M. A., Grupe, K., & Scherneck, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126693 · Cited by 18 · see citing works
FOXO: a key target in regulating aging and age-related diseases
Wang, W., Zhu, H., Jiang, Q., Shi, Y., & Wang, X. (2026) · Biogerontology · doi:10.1007/s10522-025-10380-2 · Cited by 15 · see citing works
The complex interplay between oxinflammation, mitochondrial dysfunction and lipotoxicity: Focus on their role in the pathogenesis of skeletal muscle insulin resistance and modulation by dietary fatty acids
Passaro, A., Sanz, J. M., Naumovski, N., & Sergi, D. (2024) · Advances in Redox Research · doi:10.1016/j.arres.2024.100100 · Cited by 17 · see citing works

Hepatic Insulin Signaling is Dispensable for Suppression of Glucose Output by Insulin in Vivo
Titchenell, P. M., Chu, Q., Monks, B. R., & Birnbaum, M. J. (2016)
Self-citation
Mechanisms of hepatic glucose production revealed
Greenhill, C. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.77
FoxO1 integrates direct and indirect effects of insulin on hepatic glucose production and glucose utilization
O-Sullivan, I., Zhang, W., Wasserman, D. H., Liew, C. W., Liu, J., Paik, J., DePinho, R. A., Stolz, D. B., Kahn, C. R., Schwartz, M. W., et al. (2015) · Nature Communications · doi:10.1038/ncomms8079 · Cited by 228 · see citing works
Insulin signaling is required for insulin’s direct and indirect action on hepatic glucose production
Fisher, S. J., & Kahn, C. R. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16426 · Cited by 211 · see citing works
Insulin regulates liver metabolism in vivo in the absence of hepatic Akt and Foxo1
Lu, M., Wan, M., Leavens, K. F., Chu, Q., Monks, B. R., Fernandez, S., Ahima, R. S., Ueki, K., Kahn, C. R., & Birnbaum, M. J. (2012) · Nature Medicine · doi:10.1038/nm.2686 · Cited by 396 · see citing works
Self-citation

Authors: Titchenell, P. M., Chu, Q., Monks, B. R., & Birnbaum, M. J.
Affiliations: University of Pennsylvania (US)
Corresponding author: Birnbaum, Morris J.
ORCID: Titchenell, Paul M.
Birnbaum, Morris J.
Venue: Nature Communications
Publisher: Springer Science and Business Media LLC
Published: 2015-05-12
Volume: 6
Issue: 1
Pages: 7078-7078
ISSN: 2041-1723 (ISSN-L)
DOI: 10.1038/ncomms8078
PMC: PMC4429930
OpenAlex: W240175869
Cited by: 169
References: 43
Citations by year: 2026: 7 · 2025: 13 · 2024: 11 · 2023: 14 · 2022: 18 · 2021: 15 · 2020: 15 · 2019: 11 · 2018: 19 · 2017: 24 · 2016: 14 · 2015: 8
FWCI: 9.41
Type: journal article
Language: en
Open access: gold
doi.org
Licence: www.springernature.com/gp/researchers/text-and-data-mining (tdm)
www.springernature.com/gp/researchers/text-and-data-mining (vor)
Locations: Nature Communications (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
RePEc: Research Papers in Economics (submittedVersion)
Funders: National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases (R01DK056886, F32DK101175)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › FOXO transcription factor regulation
Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
Keywords: hepatic glucose production, FOXO1, insulin receptor, Akt, gluconeogenesis, impaired glucose tolerance, insulin resistance, liver-specific knockout, postprandial glucose metabolism, hepatic glucose metabolism
MeSH terms: Forkhead Box Protein O1, Animals, Gene Expression Regulation, Gluconeogenesis, Glucose, Glucose Tolerance Test, Insulin Resistance, Liver, Male, Receptor, Insulin, RNA, Messenger, Signal Transduction, Mice, Knockout, Mice, Forkhead Transcription Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Hepatic insulin signalling is dispensable for suppression of glucose output by insulin in vivo

Abstract

Integrity signals

Claims the paper makes

Claims other papers make about this one

Self-check

Cites

Cited by

Related

Record

About these checks